InvestorsHub Logo
Followers 116
Posts 19006
Boards Moderated 0
Alias Born 08/27/2005

Re: Je3232 post# 194524

Friday, 04/15/2016 1:43:39 PM

Friday, April 15, 2016 1:43:39 PM

Post# of 401899

I want him to market and promote his company like he said he would. His words, not mine. I want a status on Canada and other generics. I want a status on ELI 201 and 202. I want to know when the FDA advisory meeting will be held. I want to his think about the PPS. Sell the company if needed to raise the price.



In other words instant gratification.
Promotion of the company is like putting the cart before the horse. First things first by getting approval of SequestOx. Launch will come with approval.

Once SepueastOx is approved I am sure you will see an all out effort to get the word out. Elite will be MARKETING their ADF opioid. They will now have an ADF opioid to market and without question approved by the FDA.

Once this is done I don't care about Canadian status. The other 2 NDAs wanted by the end of 2016 are most important. This will give Elite 3 ADF opioids going into 2017. Maybe Elite can address Canada after the other 2 NDAs are with the FDA or sometime in between. US market is first on the docket IMO.

After the two NDAs are submitted to the FDA I think we will see
even more NDAs submitted in 2017. Do they have the cash to do this? With the launch of SequestOx they will. No doubt about that.

Sell the company? Not even close. If all of the above happens Elite will be a goldmine. Selling this company for a few bucks per share would not be a very prudent move IMO. Not when Elite is worth much much more.

Nasrat knows what he is doing. He is building a world class pharmaceutical from what once was a very small pharmaceutical specializing in innovation.

With the ADF opioids coming on the market Elite will emerge as a leader in technical innovation once again. They will capture market share with numerous opioid ADFs out of the non ADF opioids currently being used in pain management.

Dont need no sale of this company for a while and do not think that is Nasrats intention.
If the company I work for was offered $7 billion and turned it down I do not see NH selling Elite anytime soon.
Elite has far more potential then the company I currently work for. It isn't even close. Other companies would love to have what Elite has. Possibilities are tremendous. So to sell out is just
a bad move at this time IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News